(2R,6R)-HYDROXYNORKETAMINE TARGETING THE BASOLATERAL AMYGDALA REGULATES FEAR MEMORY

被引：0
|
作者：
Xu, Yuanyuan [1 ]
Li, Zhenlong [2 ]
Lee, Chau-Shoun [3 ,4 ]
Peng, Hsien-Yu [3 ]
Lin, Tzer-Bin [5 ,6 ,7 ]
Hsieh, Ming-Chun [3 ]
Lai, Cheng-Yuan [8 ]
Chou, Dylan [3 ,9 ]
机构：
[1] Zunyi Med Univ, Dept Pharmacol, Zhuhai Campus, Zhuhai, Peoples R China
[2] Zunyi Med Univ, Sch Basic Med Sci, Zhuhai Campus, Zhuhai, Peoples R China
[3] MacKay Med Coll, Dept Med, Taipei, Taiwan
[4] Mackay Mem Hosp, Dept Psychiat, Taipei, Taiwan
[5] China Med Univ, Coll Med, Inst New Drug Dev, Taichung, Taiwan
[6] Taipei Med Univ, Wan Fang Hosp, Cell Physiol & Mol Image Res Ctr, Taipei, Taiwan
[7] Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei, Taiwan
[8] MacKay Med Coll, Inst Biomed Sci, Taipei, Taiwan
[9] Zunyi Med Univ, Dept Physiol, Zhuhai Campus, Zhuhai, Peoples R China
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2025年 / 28卷
关键词：
(2R; 6R)-hydroxynorketamine; long-term potentiation; basolateral amygdala; synaptic transmission; fear memory extinction;
D O I：
10.1093/ijnp/pyae059.383
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
pyae059.38
引用
收藏
页码：i218 / i218
页数：1
相关论文
共 50 条
  • [41] (2R,6R)-Hydroxynorketamine Alleviates Electroconvulsive Shock-Induced Learning Impairment by Inhibiting Autophagy
    Zhong, Xiaomei
    Ouyang, Cong
    Liang, Wanyuan
    Dai, Cunying
    Zhang, Weiru
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 297 - 304
  • [42] Simple Enantioselective Syntheses of (2R,6R)-Hydroxynorketamine and Related Potential Rapid-Onset Antidepressants
    Han, Yixin
    Reddy, Karla Mahender
    Corey, E. J.
    ORGANIC LETTERS, 2017, 19 (19) : 5224 - 5227
  • [43] (2R,6R)-Hydroxynorketamine Treatment of Rats Exposed to Repetitive Low-Level Blast Injury
    Garcia, Georgina Perez
    Perez, Gissel M. M.
    De Gasperi, Rita
    Sosa, Miguel A. Gama
    Otero-Pagan, Alena
    Abutarboush, Rania
    Kawoos, Usmah
    Statz, Jonathan K. K.
    Patterson, Jacob
    Zhu, Carolyn W. W.
    Hof, Patrick R. R.
    Cook, David G. G.
    Ahlers, Stephen T. T.
    Elder, Gregory A. A.
    NEUROTRAUMA REPORTS, 2023, 4 (01): : 197 - 217
  • [44] A Phase 1 Assessment of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (2R,6R)-Hydroxynorketamine in Healthy Volunteers
    Raja, Shruti M.
    Guptill, Jeffrey T.
    Mack, Michelle
    Peterson, Marni
    Byard, Stephen
    Twieg, Robert
    Jordan, Lynn
    Rich, Natalie
    Castledine, Richard
    Bourne, Samuel
    Wilmshurst, Martin
    Oxendine, Sarah
    Avula, Satya G. C.
    Zuleta, Helen
    Quigley, Paul
    Lawson, Sheila
    McQuaker, Stephen J.
    Ahmadkhaniha, Reza
    Appelbaum, Lawrence G.
    Kowalski, Kevin
    Barksdale, Chineta T.
    Gufford, Brandon T.
    Awan, Asaad
    Sancho, Alfredo R.
    Moore, Max C.
    Berrada, Karim
    Cogan, Gregory B.
    DeLarosa, Jesse
    Radcliffe, Jeanne
    Pao, Maryland
    Kennedy, Michelle
    Lawrence, Quentin
    Goldfeder, Lisa
    Amanfo, Leslie
    Zanos, Panos
    Gilbert, Jessica R.
    Morris, Patrick J.
    Moaddel, Ruin
    Gould, Todd D.
    Zarate, Carlos A.
    Thomas, Craig J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (05) : 1314 - 1324
  • [45] Stereochemical and structural effects of (2R,6R)-hydroxynorketamine on the mitochondrial metabolome in PC-12 cells
    Faccio, Andrea T.
    Ruperez, Francisco J.
    Singh, Nagendra S.
    Angulo, Santiago
    Tavares, Marina F. M.
    Bernier, Michel
    Barbas, Coral
    Wainer, Irving W.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2018, 1862 (06): : 1505 - 1515
  • [46] Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a rat Learned Helplessness Model: Comparison With (R)-Ketamine and (R)-Norketamine
    Shirayama, Yukihiko
    Hashimoto, Kenji
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S542 - S543
  • [47] ( 2R, 6R)Hydroxynorketamine Prevents Myocardial Ischemia Reperfusion Injury By Regulating Immune And Inflammatory Response
    Chen, Baihe
    Luo, Tao
    Kitakaze, Masafumi
    CIRCULATION RESEARCH, 2023, 133
  • [48] Common Neurotransmission Recruited in Ketamine and (2R,6R)-Hydroxynorketamine-Induced Sustained Antidepressant Effects
    Gardier, Alain
    Thu Ha Pham
    Defaix, Celine
    Xu, Xiaoming
    Deng, Shi-Xian
    Fabresse, Nicolas
    Martinez, Jean-Claude
    Brachman, Rebecca A.
    Denny, Christine A.
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S75 - S76
  • [49] Study on the antidepressant activity of (2R,6R; 2S,6S)-Hydroxynorketamine (HNK) and its derivatives
    Zang, Dongdong
    Yang, Xuemei
    Wang, Hao
    Li, Zhenxing
    Ma, Yanjun
    Liu, Jianxi
    Mei, Xi
    Li, Shupeng
    Feng, Jinxing
    Shi, Xin
    Tan, Zhen
    CLINICS, 2024, 79
  • [50] (2R,6R)-Hydroxynorketamine (HNK) plasma level predicts poor antidepressant response: is this the end of the HNK pipeline?
    Abdallah, Chadi G.
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (08) : 1245 - 1246
12345